・総説
1: ⼤槻克⼀. アポトーシスの検出 イメージング技術による現在までの研究成果と将来展
望. Isotope News 1999 Oct:2-8.
2: ⼤槻克⼀. ⾼⾎圧 −新しい治療ガイドラインに基づく治療戦略−. 季刊 東洋医学.
2005;11(3):11-14.
・主な英語論⽂
1: Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M.
Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphyusing 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid
(123I-BMIPP). Nucl Med Commun. 1994 Jun;15(6):441-7.
2: Strauss HW, Ohtsuki K. Seeing is believing. J Nucl Med. 1997
Nov;38(11):1672-4.
3: Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K,Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW. In vivo
detection and imaging of phosphatidylserine expression during programmed celldeath. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6349-54.
4: Sugihara H, Kinoshita N, Adachi Y, Taniguchi Y, Ohtsuki K, Azuma A, Adachi H,Ushijima Y, Nakagawa M, Maeda T. Early and delayed Tc-99m-tetrofosmin myocardial
SPECT in patients with left bundle branch block. Ann Nucl Med. 1998
Oct;12(5):281-6.
5: Vriens PW, Blankenberg FG, Stoot JH, Ohtsuki K, Berry GJ, Tait JF, Strauss
HW, Robbins RC. The use of technetium Tc 99m annexin V for in vivo imaging ofapoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg. 1998
Nov;116(5):844-53.
6: Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K,Kopiwoda S, Abrams MJ, Strauss HW. Imaging of apoptosis (programmed cell death)with 99mTc annexin V. J Nucl Med. 1999 Jan;40(1):184-91.
7: Blankenberg F, Ohtsuki K, Strauss HW. Dying a thousand deaths. Radionuclideimaging of apoptosis. Q J Nucl Med. 1999 Jun;43(2):170-6.
8: Ohtsuki K, Akashi K, Aoka Y, Blankenberg FG, Kopiwoda S, Tait JF, Strauss HW.
Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo
detection of apoptosis. Eur J Nucl Med. 1999 Oct;26(10):1251-8.
9: Ohtsuki K, Sugihara H, Kuribayashi T, Nakagawa M. Impairment of BMIPP
accumulation at junction of ventricular septum and left and right ventricular
free walls in hypertrophic cardiomyopathy. J Nucl Med. 1999 Dec;40(12):2007-13.
10: Blankenberg FG, Tait J, Ohtsuki K, Strauss HW. Apoptosis: the importance ofnuclear medicine. Nucl Med Commun. 2000 Mar;21(3):241-50.
11: Sugihara H, Adachi Y, Nakamura T, Ohtsuki K, Okuyama C, Ushijima Y. Longterm follow-up of myocardial perfusion and metabolic images in a patient withhypertrophic cardiomyopathy. Clin Nucl Med. 2000 Mar;25(3):206-7.
12: Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte
chemoattractant protein-1 receptor expression in experimental atherosclerotic
lesions: an autoradiographic study. Circulation. 2001 Jul 10;104(2):203-8.
13: Konishi C, Shiraishi J, Muraguchi N, Ohtsuki K, Inoue M, Tatsumi T, Azuma A,Matsubara H. Beneficial effect of cibenzoline on left ventricular pressure
gradient with sigmoid septum. Circ J. 2004 Oct;68(10):968-71.
14: Miyawaki K, Shiraishi J, Tsutsumi Y, Shiraishi E, Ohtsuki K, Inoue M, TatsumiT, Azuma A, Matsubara H. Beneficial effect of gabexate mesilate on microscopic
polyangiitis with renal dysfunction and pulmonary hemorrhage: A case report.
Angiology. 2006 Aug-Sep;57(4):522-5.
15: Doue T, Ohtsuki K, Ogawa K, Ueda M, Azuma A, Saji H, Strauss HW, Matsubara H.
Cardioprotective effects of erythropoietin in rats subjected to ischemiareperfusion injury: assessment of infarct size with 99mTc-annexin V. J Nucl Med.
2008 Oct;49(10):1694-700.
16: Ogawa K, Ohtsuki K, Shibata T, Aoki M, Nakayama M, Kitamura Y, Ono M, Ueda M,DoueT, Onoguchi M, Shiba K, Odani A. Development and evaluation of a novel(99m)Tc-labeled annexin A5 for early detection of response to chemotherapy. PLoSOne. 2013 Dec 4;8(12): e81191.
・主な⽇本語論⽂
1: Sugihara H, Adachi H, Umamoto I, Harada Y, Nakagawa T, Ohtsuki K, Kamide T,Tanaka T, Shiga K, Katsume H, et al. [Effect of age on visualization of rightatrium by thallium-201 myocardial scintigraphy]. Kaku Igaku. 1991
Oct;28(10):1173-6. Japanese.
2: Ohtsuki K, Sugihara H, Umamoto I, Harada Y, Shiga K, Nakamura T, Nakagawa T,Azuma A, Kohno Y, Katsume H, et al. [Clinical evaluation of 123I-BMIPP
myocardial scintigraphy in patients with hypertrophic cardiomyopathy]. Kokyu To
Junkan. 1992 Feb;40(2):175-81. Japanese.
3: Kawata K, Okada M, Taniguchi Y, Ohtsuki K, Shiga K, Katahira T, Nakamura T,Azuma A, Sugihara H, Inoue D, et al. [Repeated blackout in a patient withaccelerated idioventricular rhythm]. Kokyu To Junkan. 1992 Jul;40(7):699-703.
Japanese.
4: Sugihara H, Taniguchi Y, Ohtsuki K, Umamoto I, Nakazawa T, Shima T, Nakamura
T, Azuma A, Kohno Y, Nakagawa M. [Assessment of myocardial perfusion
abnormalities in patients with apical hypertrophic cardiomyopathy using exercise
201Tl scintigraphy]. Kokyu To Junkan. 1993 Nov;41(11):1089-93. Japanese.
5: Taniguchi Y, Sugihara H, Ohtsuki K, Umamoto I, Nakagawa T, Shiga K, Nakamura
T, Azuma A, Kohno Y, Nakagawa M, et al. [Effect of verapamil on myocardialischemia in patients with hypertrophic cardiomyopathy: evaluation by exercise
thallium-201 SPECT]. J Cardiol. 1994 Jan-Feb;24(1):45-51. Japanese.
6: Ohtsuki K, Sugihara H, Taniguchi Y, Umamoto I, Nakagawa T, Nakamura T, Azuma
A, Kohno Y, Adachi H, Ochiai M, et al. [Evaluation of myocardial perfusion andventricular shape in hypertrophic cardiomyopathy using 99mTc-tetrofosmin
scintigraphy: comparison with 201Tl myocardial scintigraphy]. Kaku Igaku. 1994
Apr;31(4):309-18. Japanese.

7: Taniguchi Y, Sugihara H, Terada K, Ito K, Ohtsuki K, Shiga K, Shima T,Nakamura T, Azuma A, Kohno Y, et al. [Myocardial ischemia and abnormality ofcardiac sympathetic nervous function in apical hypertrophic cardiomyopathy]. JCardiol. 1994 Jul-Aug;24(4):293-8. Japanese.
8: Ohtsuki K, Sugihara H, Ito K, Matsumoto K, Taniguchi Y, Terada K, Nakagawa
T, Shima T, Kuribayashi T, Ochiai M, et al. [The characteristic feature of
myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic
acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy]. KakuIgaku. 1995 Apr;32(4):377-85. Japanese.
9: Terada K, Sugihara H, Shiga K, Ohtsuki K, Ito K, Taniguchi Y, Azuma A, Kohno
Y, Miyao K, Nakagawa M. [Clinical evaluation of 123I-metaiodobenzylguanidine
myocardial scintigram in patients with valvular heart disease]. J Cardiol. 1995
May;25(5):247-53. Japanese.
10: Matsumoto K, Sugihara H, Ito K, Terada K, Taniguchi Y, Ohtsuki K, Nakata T,
Ushijima Y, Maeda T, Nakagawa M. [123I-metaiodobenzylguanidine myocardial
scintigraphy in a case of pheochromocytoma before and after resection of it].
Kaku Igaku. 1995 Sep;32(9):1023-8. Japanese.
11: Ito K, Sugihara H, Terada K, Matsumoto K, Taniguchi Y, Ohtsuki K, Miyazaki
H, Nakagawa T, Azuma A, Maeda T, et al. [Assessment of myocardial fatty acidmetabolism in patients with vasospastic angina using 123I-BMIPP myocardial
SPECT]. Kaku Igaku. 1995 Oct;32(10):1099-106. Japanese.
12: Ohtsuki K. Impairment of myocardial fatty acid metabolism in patients with hypertrophic
cardiomyopathy. J Kyoto Pref. Univ. Med. 1996 April;105(4):561-80. Japanese.